Loading…
Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma
Objectives The study was to develop a Gd-EOB-DTPA-enhanced MRI radiomics model for preoperative prediction of VETC and patient prognosis in hepatocellular cancer (HCC). Methods The study included 182 (training cohort: 128; validation cohort: 54) HCC patients who underwent preoperative Gd-EOB-DTPA-en...
Saved in:
Published in: | European radiology 2022-02, Vol.32 (2), p.959-970 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
The study was to develop a Gd-EOB-DTPA-enhanced MRI radiomics model for preoperative prediction of VETC and patient prognosis in hepatocellular cancer (HCC).
Methods
The study included 182 (training cohort: 128; validation cohort: 54) HCC patients who underwent preoperative Gd-EOB-DTPA-enhanced MRI. Volumes of interest including intratumoral and peritumoral regions were manually delineated in the hepatobiliary phase images, from which 1316 radiomics features were extracted. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the useful features. Clinical, intratumoral, peritumoral, combined radiomics, and clinical radiomics models were established using machine learning algorithms. The Kaplan–Meier survival analysis was used to assess early recurrence and progression-free survival (PFS) in the VETC + and VETC- patients.
Results
In the validation cohort, the area under the curves (AUCs) of radiomics models were higher than that of the clinical model using random forest (all
p
0.05). Early recurrence and PFS were significantly different between the PR-predicted VETC + and VETC- HCC patients (
p
|
---|---|
ISSN: | 0938-7994 1432-1084 |
DOI: | 10.1007/s00330-021-08250-9 |